Latest filing: Kwality Pharmaceuticals Ltd - 539997 - Disclosure Under Regulation 30 Of SEBI LODR
ObservedCompany dossier
Kwality Pharmaceuticals
NSE:KPL · ISIN INE552U01010
- Close
- ₹2,604 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Kwality Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 54.87% and public 45.13% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Kwality Pharmaceuticals Ltd - 539997 - Disclosure Under Regulation 30 Of SEBI LODR
BSE · exchange filing
Observed
Source filing Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window
BSE · exchange filing
Observed
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Resignation of Director
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 54.87%
- Public
- 45.13%
- Employee trust
- N/A
Observed BSE shareholding XBRL